KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX
Titel:
KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX
Auteur:
Lee, Dae-Won Kim, Kyung Ju Han, Sae-Won Lee, Hyun Jung Rhee, Ye Young Bae, Jeong Mo Cho, Nam-Yun Lee, Kyung-Hun Kim, Tae-Yong Oh, Do-Youn Im, Seock-Ah Bang, Yung-Jue Jeong, Seung-Yong Park, Kyu Joo Park, Jae-Gahb Kang, Gyeong Hoon Kim, Tae-You